‘For me, it didn’t seem as drastic a step as being controlled by insulin’: A qualitative investigation of expectations and experiences of non‐insulin injectable therapy among adults with type 2 diabetes-Reference-Cited by-同舟云学术

‘For me, it didn’t seem as drastic a step as being controlled by insulin’: A qualitative investigation of expectations and experiences of non‐insulin injectable therapy among adults with type 2 diabetes

Published:2021-09-04 Issue:2 Volume:39 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Holmes‐Truscott Elizabeth¹²^ORCID,Schipp Jasmine¹²³^ORCID,Dunning Trisha⁴,Furler John⁵,Hagger Virginia⁴^ORCID,Holloway Edith E.¹²,Manski‐Nankervis Jo‐Anne⁵^ORCID,Shaw Jonathan E.⁶,Skinner Timothy⁷⁸,Speight Jane¹²^ORCID

Affiliation:

1. School of Psychology Deakin University Geelong Victoria Australia

2. The Australian Centre for Behavioural Research in Diabetes Diabetes Victoria North Melbourne Victoria Australia

3. Department of Public Health University of Copenhagen Copenhagen Denmark

4. Faculty of Health School of Nursing and Midwifery Barwon Health Partnership Deakin University Burwood Victoria Australia

5. Department of General Practice The University of Melbourne Carlton Victoria Australia

6. Baker Heart and Diabetes Institute Melbourne Victoria Australia

7. La Trobe Rural Health School La Trobe University Melbourne Victoria Australia

8. Department of Psychology University of Copenhagen Copenhagen Denmark

Funder

Deakin University

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14681

Reference30 articles.

1. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2. Psychosocial aspects and contributions of behavioural science to medication‐taking for adults with type 2 diabetes

3. Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?

4. Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods Study;Clinical Diabetes;2024-01-22

2. The protective effects of SGLT-2 inhibitors, GLP-1 receptor agonists, and RAAS blockers against renal injury in patients with type 2 diabetes;International Urology and Nephrology;2022-08-29